News & HighlightsNews
Luciano Marraffini selected as a Blavatnik National Award finalist
Luciano Marraffini, an assistant professor and head of the Laboratory of Bacteriology, has been named a finalist in the life sciences by the Blavatnik National Awards for Young Scientists, the New York Academy of Sciences announced on May 20. Marraffini, who studies the CRISPR-Cas systems that en...
A. James Hudspeth elected to the American Philosophical Society
A. James Hudspeth, F.M. Kirby Professor and head of the Laboratory of Sensory Neuroscience, has been elected to the American Philosophical Society in the biological sciences, the society has announced. The American Philosophical Society is an honorary society that elects new members each year w...
In the News - WSJ - River Campus
Major Donations Bolster Hospital, Medical Research   "Rockefeller University plans to announce a $100 million gift from the Kravis foundation to build a laboratory research building that will be the centerpiece of a 2-acre campus extension over FDR Drive from East 64th to East 68th. That building...
The Marie-Josée and Henry R. Kravis Foundation provides landmark gift of $100 Million to The Rockefeller University
New research center will help attract the best talent to make transformative discoveries Marc Tessier-Lavigne, president of The Rockefeller University, today announced a leadership gift of $100 million from The Marie-Josée and Henry R. Kravis Foundation to help create a new laboratory building t...
Gaby Maimon honored with a McKnight Scholar Award
Gaby Maimon, assistant professor at The Rockefeller University and head of the Laboratory of Integrative Brain Function, has received a McKnight Scholar Award for his research on the neuronal basis for behavior. Maimon and five other young scientists will each receive $75,000 per year for three y...
In the News - Forbes - Tessier-Lavigne
Genentech Brain Trust Leaves With $217 Million For New Startup To Fight Alzheimer's And Parkinson's   "Three former top researchers at Genentech, the legendary biotech that is now part of Roche Holding, have raised $217 million in venture capital to start a new company, Denali Therapeutics, focus...
Research shows how antibodies produce vaccine-like effect against tumors
The problem with traditional cancer treatments is that their effects don’t always last:  Stop the therapy and the disease may return. That’s why antibody therapy — which not only kills tumors, but also appears to train the body’s own defenses to recognize them — has such promise. New rese...
Fragments of tRNA suggest a novel mechanism for cancer progression
For years, scientists have been puzzled by the presence of short stretches of genetic material floating inside a variety of cells, ranging from bacteria to mammals, including humans. These fragments are pieces of the genetic instructions cells use to make proteins, but are too short a length to s...
Rockefeller scientists resolve long-standing debate over how many bacteria fight off invaders
Every inch of our body, inside and out, is oozing with bacteria. In fact, the human body carries 10 times the number of bacterial cells as human cells. Many are our friends, helping us digest food and fight off infections, for instance. But much about these abundant organisms, upon which our life...
Paul Nurse to receive Friesen International Prize
Paul Nurse, president emeritus at Rockefeller, has been awarded the Henry G. Friesen International Prize in Health Research. A Canadian prize, established by the Friends of Canadian Institutes of Health Research in collaboration with the Canadian Academy of Health Sciences, the prize honors excep...
View
View